An experimental coronavirus vaccine developed by China’s Sinovac Biotech appeared to be safe in a late-stage clinical trial in Brazil, preliminary results showed on Monday.São Paulo’s Butantan Institute, one of Brazil’s leading biomedical research centers, … .
Although there is not a specific DHHS tracking of COVID-19 case and death totals for health-care providers, there has been with long-term care facilities.As of 4 p.m. Friday, there have been 18,535 COVID-19 cases and … .
Technology has completely changed the practice of modern medicine. From telehealth to electronic patient/health records, innovation is abundant in clinical medicine. However, as with any form of technology and the movement of information on virtual … .
Maine’s system for distributing an eventual COVID-19 vaccine will prioritize racial equity and protecting health care workers and the elderly, according to a plan the state submitted to the federal government on Friday. If there’s … .
The Phase 3 trial of Johnson & Johnson’s COVID-19 vaccine candidate has been paused as the company investigates what it says is a study participant’s “unexplained illness.” Cheryl Gerber/AP hide caption toggle caption … Johnson … .
Researchers have recovered and identified the various types of neutralizing antibodies for SARS-CoV-2 from convalescent COVID-19 patients. Of these, they identified three that are extremely potent and could be used to develop treatment therapies. As … .
The search for vaccine to end the corona virus epidemic is very good news for the world. Chinese scientists have made pictures of this killer virus for the first time in the world. There have … .
This week’s publication by the FDA of its guidelines for emergency use authorization for COVID-19 experimental vaccines affirms the agency’s commitment to base good medicine on sound science. The American people should feel reassured, even though that … .
There could be enough coronavirus vaccine doses for every American as early as March of 2021. CNBC reports Health and Human Services (HHS) Secretary Alex Azar made the projection on Thursday during a keynote speech at … .
Drugmakers live and die by the exclusivity provided by patents on their medications. Generic competition or even a branded competitor can substantially cut a company’s market share. But Moderna (NASDAQ:MRNA) is putting society ahead of … .